ABBOTT's TRANXENE "ANXIOSELECTIVE" PROMOTION ENDING: FDA SAYS NO CLINICALLY SIGNIFICANT DIFFERENCE EXISTS BETWEEN TRANXENE & OTHER ANXIOLYTICS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".